Skip to Content
Merck
All Photos(2)

Documents

P50900

Sigma-Aldrich

Propargylamine

98%

Synonym(s):

2-Propynylamine, 3-Amino-1-propyne

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
HC≡CCH2NH2
CAS Number:
2450-71-7
Molecular Weight:
55.08
Beilstein:
773681
EC Number:
219-513-8
MDL number:
MFCD00008198
UNSPSC Code:
12352100
PubChem Substance ID:
24898592
NACRES:
NA.22

Quality Level

200

Assay

98%

contains

≤2.5% water

refractive index

n20/D 1.449 (lit.)

bp

83 °C (lit.)

density

0.86 g/mL at 25 °C (lit.)

storage temp.

2-8°C

SMILES string

NCC#C

InChI

1S/C3H5N/c1-2-3-4/h1H,3-4H2

InChI key

JKANAVGODYYCQF-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Application

Synthesis of a chiral, fluorescent macrocycle by 1,3-dipolar cycloaddition of propargyl amides of carbohydrate-linked amino acids and 9,10-bis(azidomethyl)anthracene.

accessory

Product No.
Description
Pricing

Signal Word

Danger

Hazard Statements

H225,H302,H310,H314

Hazard Classifications

Acute Tox. 2 Dermal - Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Liq. 2 - Skin Corr. 1B

Storage Class Code

3 - Flammable liquids

WGK

WGK 3

Flash Point(F)

42.8 °F - closed cup

Flash Point(C)

6 °C - closed cup

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Irene Bolea et al.
Journal of neural transmission (Vienna, Austria : 1996), 120(6), 893-902 (2012-12-15)
Alzheimer's disease (AD) is a complex neurodegenerative disorder with a multifaceted pathogenesis. There are at present three Food and Drug Administration-approved drugs based on the "one drug, one target" paradigm (donepezil, galantamine and rivastigmine) that improve symptoms by inhibiting acetylcholinesterase.
Synthesis, 3141-3141 (2006)
Simona Pilotto et al.
Proceedings of the National Academy of Sciences of the United States of America, 112(9), 2752-2757 (2015-03-03)
With its noncatalytic domains, DNA-binding regions, and a catalytic core targeting the histone tails, LSD1-CoREST (lysine-specific demethylase 1; REST corepressor) is an ideal model system to study the interplay between DNA binding and histone modification in nucleosome recognition. To this
Orit Bar-Am et al.
Journal of Alzheimer's disease : JAD, 21(2), 361-371 (2010-06-18)
The anti-Parkinsonian, irreversible, selective monoamine oxidase (MAO)-B inhibitors, selegiline (deprenyl, (R)-N-methyl-N-(1-phenylpropan-2-yl) prop-2-yn-1-amine) and rasagiline (Azilect, N-propargyl-1(R)-aminoindan), have been proven to possess neuroprotective/neurorestorative activities in cell cultures and animal models of neurodegenerative diseases. Structure-activity studies provide evidence that neuroprotection is associated
David Aguilar et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 16(30), 9287-9296 (2010-06-29)
Propargylamines can be obtained from secondary amines and terminal alkynes in chlorinated solvents by a three- and two-component synthesis catalyzed by gold compounds and nanoparticles (Au-NP) under mild conditions. The use of dichloromethane allows for the activation of two C-Cl
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service